Paragraph 8 Amendment of the Blood Safety and Quality Regulations 2005I1
United Kingdom
In regulation 1A of the Blood Safety and Quality Regulations 2005 M1, after paragraph (10) insert—
“(10A)Paragraph 7.1 is to be read F1as if the reference to “Directive 2003/94/EC” were to “the Good Manufacturing Practice Directive, within the meaning of F2paragraph (a) of the definition of that term in regulation 8(1) of the Human Medicines Regulations 2012.”.
Annotations
Textual amendments
- F1
Words in Sch. 8 para. 8 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 194(b)(i)
- F2
Words in Sch. 8 para. 8 inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 194(b)(ii)
Marginal citations
- M1
S.I. 2005/50. Regulation 1A was inserted by S.I. 2019/4.
Commencement
- I1
Sch. 8 para. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1